David Escors

17PUBLICATIONS
30CO-AUTHORS
Proteins and peptidesMolecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 10, 2024
Fractalkine in Health and Disease.

Claudia Rodriguez, Luisa Chocarro, Miriam Echaide

|Jul 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio

|Jan 10, 2024
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra

|Oct 04, 2023
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.

Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja

|Jun 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio

|Jun 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona

Pageof 3

Frequent Collaborators

12 joint publications

Ana Isabel Bocanegra

11 joint publications

Ester Blanco

9 joint publications

Hugo Arasanz

8 joint publications

Luisa Chocarro